Literature DB >> 14726154

A sesquiterpene lactone, costunolide, interacts with microtubule protein and inhibits the growth of MCF-7 cells.

Claudia Bocca1, Ludovica Gabriel, Francesca Bozzo, Antonella Miglietta.   

Abstract

Costunolide is an active sesquiterpene lactone of medicinal herbs with anti-inflammatory and potential anti-cancer activity. Nevertheless, the pharmacological pathways of costunolide have not yet been fully elucidated. In this study we showed that costunolide exerts a dose-dependent antiproliferative activity in the human breast cancer MCF-7 cells. In addition, light microscopy observations indicated that costunolide affected nuclear organization and reorganized microtubule architecture. The antiproliferative and antimicrotubular effects of costunolide were not influenced by paclitaxel, well-known microtubule-stabilizing anticancer agent. The microtubule-interacting activity of costunolide was confirmed by in vitro studies on purified microtubular protein. In fact, costunolide demonstrated polymerizing ability, by inducing the formation of well organized microtubule polymers. Our data suggest an interaction of costunolide with microtubules, which may represent a new intracellular target for this drug.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726154     DOI: 10.1016/j.cbi.2003.10.008

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  11 in total

1.  Effect of sesquiterpene lactone coronopilin on leukaemia cell population growth, cell type-specific induction of apoptosis and mitotic catastrophe.

Authors:  R Cotugno; R Fortunato; A Santoro; D Gallotta; A Braca; N De Tommasi; M A Belisario
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

2.  Anticancer mechanism of 7-α-hydroxyfrullanolide on microtubules and computational prediction of its target binding in triple-negative breast cancer cells.

Authors:  Siriphorn Chimplee; Carl Smythe; Varomyalin Tipmanee; Suchada Sukrong; Kanyanatt Kanokwiroon
Journal:  PeerJ       Date:  2022-05-27       Impact factor: 3.061

3.  Dissecting the role of the tubulin code in mitosis.

Authors:  Luísa T Ferreira; Ana C Figueiredo; Bernardo Orr; Danilo Lopes; Helder Maiato
Journal:  Methods Cell Biol       Date:  2018       Impact factor: 1.441

4.  Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells.

Authors:  Chia-Yuan Liu; Hsun-Shuo Chang; Ih-Sheng Chen; Chih-Jen Chen; Ming-Ling Hsu; Shu-Ling Fu; Yu-Jen Chen
Journal:  Radiat Oncol       Date:  2011-05-30       Impact factor: 3.481

Review 5.  Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone.

Authors:  Xuejing Lin; Zhangxiao Peng; Changqing Su
Journal:  Int J Mol Sci       Date:  2015-05-13       Impact factor: 5.923

6.  Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.

Authors:  Rebecca A Whipple; Michele I Vitolo; Amanda E Boggs; Monica S Charpentier; Keyata Thompson; Stuart S Martin
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

Review 7.  Emerging Anti-Mitotic Activities and Other Bioactivities of Sesquiterpene Compounds upon Human Cells.

Authors:  Alessandra Bosco; Roy M Golsteyn
Journal:  Molecules       Date:  2017-03-13       Impact factor: 4.411

8.  Antimicrobial Effects and Active Compounds of the Root of Aucklandia Lappa Decne (Radix Aucklandiae).

Authors:  Xuewei Cai; Chunping Yang; Guangwei Qin; Min Zhang; Yan Bi; Xiaoyan Qiu; Liya Lu; Huabao Chen
Journal:  Front Chem       Date:  2022-04-06       Impact factor: 5.545

9.  Induction of apoptosis by costunolide in bladder cancer cells is mediated through ROS generation and mitochondrial dysfunction.

Authors:  Azhar Rasul; Rui Bao; Mahadev Malhi; Bing Zhao; Ichiro Tsuji; Jiang Li; Xiaomeng Li
Journal:  Molecules       Date:  2013-01-24       Impact factor: 4.411

10.  Costunolide Induces Autophagy and Apoptosis by Activating ROS/MAPK Signaling Pathways in Renal Cell Carcinoma.

Authors:  Dian Fu; Ding Wu; Wen Cheng; Jianping Gao; Zhengyu Zhang; Jingping Ge; Wenquan Zhou; Zhenyu Xu
Journal:  Front Oncol       Date:  2020-10-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.